Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-065918)

Filing Details

Accession Number:: 0001209191-17-065918
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-12-15 16:21:16
Reporting Period:: 2017-12-14

Accepted Time:: 2017-12-15 16:21:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
786947	Acura Pharmaceuticals Inc	ACUR	Pharmaceutical Preparations (2834)	110853640

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1431759	B Robert Jones	C/O Acura Pharmaceuticals, Inc. 616 N North Court Palatine IL 60067	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-12-14	400,000	$0.10	412,555	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Reporting Person is among buyers of shares in a private transaction pursuant to a stock purchase agreement entered into with Galen Partners III, LP, Galen Employee Fund III, LP and Galen Partners International III, LP in connection with their disposition of substantially all of their shares of Issuer.